| Samuel S Mccaulley, CRNA | |
|
8212 Summa Ave, Baton Rouge, LA 70809-3421 | |
| (225) 769-4403 | |
| (225) 769-3842 |
| Full Name | Samuel S Mccaulley |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 8212 Summa Ave, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497877112 | NPI | - | NPPES |
| RN065575 AP01548 | Other | LA | LA AP LIC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN065575 AP01548 (Louisiana) | Primary |
| Entity Name | Eunice Anesthesiology Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386681278 PECOS PAC ID: 2365430758 Enrollment ID: O20040504001163 |
News Archive
Changes in health insurance status - whether gaining or losing coverage - are associated with increased likelihood of an emergency department (ED) visit, researchers said. Among some 160,000 people completing the National Health Interview Survey (NHIS) from 2004 to 2009, both newly insured and newly uninsured respondents reported using an ED in excess of 30% more often than those who were continuously insured.
This morning, the U.S. Senate voted to move forward with health care reforms that will begin to bring needed relief to millions of Americans struggling with high costs and discriminatory insurance company practices.
Typically, researchers create microfluidic devices using the same lithographic techniques and tools used to fabricate computer chips. Lithography is expensive and slow, factors that could limit the ultimate utility of microfluidic devices in clinical applications.
The Charité - Medical University of Berlin has today begun the implementation of the clinical study phase I/II with the renal cancer medication MGN1601 (ASET Study). With this MOLOGEN AG product, an innovative cell-based gene therapy for the treatment of advanced renal cancer is entering the first important test phase.
› Verified 8 days ago
| Entity Name | Anesthesia Associates Of Opelousas, Apmc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669475935 PECOS PAC ID: 8628067709 Enrollment ID: O20040512000769 |
News Archive
Changes in health insurance status - whether gaining or losing coverage - are associated with increased likelihood of an emergency department (ED) visit, researchers said. Among some 160,000 people completing the National Health Interview Survey (NHIS) from 2004 to 2009, both newly insured and newly uninsured respondents reported using an ED in excess of 30% more often than those who were continuously insured.
This morning, the U.S. Senate voted to move forward with health care reforms that will begin to bring needed relief to millions of Americans struggling with high costs and discriminatory insurance company practices.
Typically, researchers create microfluidic devices using the same lithographic techniques and tools used to fabricate computer chips. Lithography is expensive and slow, factors that could limit the ultimate utility of microfluidic devices in clinical applications.
The Charité - Medical University of Berlin has today begun the implementation of the clinical study phase I/II with the renal cancer medication MGN1601 (ASET Study). With this MOLOGEN AG product, an innovative cell-based gene therapy for the treatment of advanced renal cancer is entering the first important test phase.
› Verified 8 days ago
| Entity Name | Ville Platte Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285811927 PECOS PAC ID: 4486630878 Enrollment ID: O20040629000146 |
News Archive
Changes in health insurance status - whether gaining or losing coverage - are associated with increased likelihood of an emergency department (ED) visit, researchers said. Among some 160,000 people completing the National Health Interview Survey (NHIS) from 2004 to 2009, both newly insured and newly uninsured respondents reported using an ED in excess of 30% more often than those who were continuously insured.
This morning, the U.S. Senate voted to move forward with health care reforms that will begin to bring needed relief to millions of Americans struggling with high costs and discriminatory insurance company practices.
Typically, researchers create microfluidic devices using the same lithographic techniques and tools used to fabricate computer chips. Lithography is expensive and slow, factors that could limit the ultimate utility of microfluidic devices in clinical applications.
The Charité - Medical University of Berlin has today begun the implementation of the clinical study phase I/II with the renal cancer medication MGN1601 (ASET Study). With this MOLOGEN AG product, an innovative cell-based gene therapy for the treatment of advanced renal cancer is entering the first important test phase.
› Verified 8 days ago
| Entity Name | Savoy Medical Management Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477882033 PECOS PAC ID: 1557403953 Enrollment ID: O20100427000030 |
News Archive
Changes in health insurance status - whether gaining or losing coverage - are associated with increased likelihood of an emergency department (ED) visit, researchers said. Among some 160,000 people completing the National Health Interview Survey (NHIS) from 2004 to 2009, both newly insured and newly uninsured respondents reported using an ED in excess of 30% more often than those who were continuously insured.
This morning, the U.S. Senate voted to move forward with health care reforms that will begin to bring needed relief to millions of Americans struggling with high costs and discriminatory insurance company practices.
Typically, researchers create microfluidic devices using the same lithographic techniques and tools used to fabricate computer chips. Lithography is expensive and slow, factors that could limit the ultimate utility of microfluidic devices in clinical applications.
The Charité - Medical University of Berlin has today begun the implementation of the clinical study phase I/II with the renal cancer medication MGN1601 (ASET Study). With this MOLOGEN AG product, an innovative cell-based gene therapy for the treatment of advanced renal cancer is entering the first important test phase.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Samuel S Mccaulley, CRNA 8212 Summa Ave, Baton Rouge, LA 70809-3421 Ph: (225) 769-4403 | Samuel S Mccaulley, CRNA 8212 Summa Ave, Baton Rouge, LA 70809-3421 Ph: (225) 769-4403 |
News Archive
Changes in health insurance status - whether gaining or losing coverage - are associated with increased likelihood of an emergency department (ED) visit, researchers said. Among some 160,000 people completing the National Health Interview Survey (NHIS) from 2004 to 2009, both newly insured and newly uninsured respondents reported using an ED in excess of 30% more often than those who were continuously insured.
This morning, the U.S. Senate voted to move forward with health care reforms that will begin to bring needed relief to millions of Americans struggling with high costs and discriminatory insurance company practices.
Typically, researchers create microfluidic devices using the same lithographic techniques and tools used to fabricate computer chips. Lithography is expensive and slow, factors that could limit the ultimate utility of microfluidic devices in clinical applications.
The Charité - Medical University of Berlin has today begun the implementation of the clinical study phase I/II with the renal cancer medication MGN1601 (ASET Study). With this MOLOGEN AG product, an innovative cell-based gene therapy for the treatment of advanced renal cancer is entering the first important test phase.
› Verified 8 days ago
Toni Tolar, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 8325 Kelwood Ave, Baton Rouge, LA 70806 Phone: 225-929-7600 Fax: 225-930-7524 | |
Holli B Cordell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7145 Perkins Road, Baton Rouge, LA 70808 Phone: 225-769-4403 Fax: 225-769-4403 | |
Amy Johnson, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7777 Hennessy Blvd, Suite 301, Baton Rouge, LA 70808 Phone: 225-214-6438 | |
Mrs. Courtney Day Passman, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7145 Perkins Road, Baton Rouge, LA 70808 Phone: 225-765-3111 Fax: 225-765-3114 | |
Denise N Baumgartner, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 8212 Summa Ave, Baton Rouge, LA 70809 Phone: 225-769-4403 Fax: 225-769-3842 | |
Kaley Mcclure, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5000 Hennessy Blvd, Baton Rouge, LA 70808 Phone: 225-765-8541 | |
Alton J Ardoin, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 7855 Howell Blvd, Baton Rouge, LA 70807 Phone: 225-358-4900 |